Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Aurora Cannabis Inc (NQ: ACB )

4.490 +0.130 (+2.98%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Aurora Cannabis Inc

< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
Europe Says Thanks But We'll Do It Ourselves - Canada Leads In Raw Cannabis Exports, Not Oil
While dried flower exports have flourished, the growth of Canada's cannabis extracts, including oils and vapes, has been more erratic. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold?
In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), announced on Tuesday developments in cannabis science from Aurora's research and genetics facility, Aurora Coast."As a company committed to leading the... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunities
Aurora Cannabis (NASDAQ: ACB) stock finds support at $4.16 amid Fibonacci analysis and bullish divergence. Learn key levels for traders. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
German Cannabis: 20 Tons, 10M Grams - And That's Only 0.3% Of The Market, What's Missing?
Medical cannabis users still represent less than 0.3% of the population, indicating significant potential for market expansion. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Canopy Growth, Aurora And Another Cannabis Giant Unveil Product Innovations, Here's What's New
Cannabis company Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) is launching the award-winning California-grown Claybourne brand in Canada, via an exclusive licensing agreement. Canadian medical... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Nov 18
The past, present and future of the Canadian cannabis sector. 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Uruguay's Cannabis Industry Struggles Amid Export Barriers, Price Drops
Uruguay's cannabis sector faces export challenges and price drops. Despite setbacks, new strains and investor interest offer hope for growth. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Aurora vs. Canopy & Tilray: Which NASDAQ-Listed Cannabis Stock Offers The Best Growth Potential?
Aurora's international medical cannabis business bolstered its results, with European sales doubling quarter-over-quarter. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Aurora Cannabis (ACB) Q2 2025 Earnings Call Transcript
ACB earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Cannabis Earnings
Exposures Cannabis Financial
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Aurora Flexed Its Global Medical Cannabis Muscles In Q2
Aurora's leadership in global medical cannabis and ability to capitalize on opportunities within rapidly growing markets such as Australia, Germany, Poland, and the UK was clearly demonstrated in Q2... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
Aurora Cannabis Reports Strong Q2 Growth Driven By International Medical Marijuana Sales
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tilray, High Tide, Glass House: How Top Cannabis Companies Deal With Financial Pressures
Discover how cannabis stocks like Tilray, High Tide, and Glass House adapt strategies amid election uncertainty and market volatility. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Sink Amid Broader Market Decline And Election Jitters
Cannabis stocks drop amid broader market downturn and election uncertainty, with major players like Tilray and Aurora Cannabis w/ losses. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Rally: Canopy, Aurora, SNDL, OrganiGram And Others See Gains
Cannabis stocks rally as Canopy Growth, Aurora Cannabis, SNDL, and OrganiGram show positive momentum. We look at resistance levels... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 23, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Marijuana Stock Movers For October 22, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Movers For October 22, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
Aurora Cannabis Launches Innovative THC Oil Products In Australia To Meet Diverse Patient Needs
Aurora Cannabis together with MedReleaf Australia, announced on Wednesday an enhanced product range of premium medical cannabis oil in Australia. The Canadian medical cannabis giant said the new... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Bullish Monday For Marijuana Stocks - Body and Mind, Global Compliance Among Top Gainers
Via Benzinga
Topics Cannabis
Exposures Cannabis
The Ever-Evolving Cannabis Industry: These Are Latest Leadership Changes You Should Know About
The U.S. Hemp Roundtable made headlines in early September as its board of directors welcomed two distinguished leaders from the hemp beverage sector to its officer ranks. New York's chief equity... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Is It Time to Load Up on Aurora Cannabis Stock?
This Canadian pot stock has defied the broader downturn among its peer group in 2024. 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Why Canopy's 'Brand-First' Strategy Could Set It Apart From Tilray And Aurora – Here's What Investors Should Watch
Senior analyst Pablo Zuanic notes Canopy USA's assets position it for growth, with added potential from federal regulatory changes. 
Via Benzinga
Cannabis Regulation In Latin America: Towards An Integrated Market Or Stagnation?
By Pablo Fazio 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Why Weed Aroma Matters: Aurora Cannabis Collaborates In Study On Marijuana Smells
Canadian medical cannabis company Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) announced on Wednesday a research grant provided to the University of British Columbia (UBC) by Genome British Columbia.... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
What's Going On With Tilray Brands Stock Monday?
Tilray Brands stock is trading higher on Monday, along with other shares in the cannabis sector, following a report suggesting that Vice President Kamala Harris wants to legalize marijuana. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Companies Delisted From Major Stock Exchanges In 2024: What Went Wrong?
Several cannabis companies faced delisting in 2024, including Bright Green and Aurora, due to financial struggles. Learn what happened here.. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stock Gainers And Losers From September 24, 2024
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
45 46 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.